Treatment of advanced cancer with active immunization.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000633:toxicity; D000906:Antibodies / Q000032:analysis; D000937:Antigen-Antibody Reactions; D001943:Breast Neoplasms / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D006801:Humans; D006967:Hypersensitivity; D007167:Immunotherapy; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D011817:Rabbits; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy; D005719:gamma-Globulins / Q000627:therapeutic use*
D000903:Antibiotics, Antineoplastic; D000906:Antibodies; D005719:gamma-Globulins; D008727:Methotrexate